George Massaro, Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 178 shares at $232.79 ($41K) on 2022-05-09, disclosed to the SEC on 2022-05-11.
Scheduled sale ($41k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $228.62 | 24 | $5K | 13.3% |
| 2 | $229.90 | 88 | $20K | 49.2% |
| 3 | $230.33 | 15 | $3K | 8.4% |
| 4 | $231.88 | 15 | $3K | 8.5% |
| 5 | $232.79 | 13 | $3K | 7.4% |
| 6 | $235.23 | 15 |
| $4K |
| 8.6% |
| 7 | $238.06 | 8 | $2K | 4.6% |
| Total | $230.96 avg | 178 | $41K | 100% |
| Filing → |
| CRL | SELL | 2024-05-16 | $78K | — | Filing → |
| CRL | SELL | 2023-05-15 | $111K | — | Filing → |
| CRL | SELL | 2021-09-01 | $2.2M | — | Filing → |